108776 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Macrophages, e.g. Kuepfer cells in the liver; Monocytes
Method for Manufacturing Natural Killer T (NKT) Cell-Stimulating Dendritic Cells, Method for Manufacturing Cell Compositions containing the NKT Cell Stimulating Dendritic Cells, NKT Cell, and Cell Composition Thereof
#2ENGINEERING AND IMAGING OF ECHOGENIC PHAGOCYTOTIC CELLS
#3METHOD TO CHANGE THE POLARIZATION OF TUMOR ASSOCIATED MACROPHAGES BY EXPOSING THEM TO A SOURCE OF RADIATION IN THE PRESENCE OF MAGNETOSOMES
#4METHOD OF DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HEMATOPOIETIC PRECURSOR AND STEM CELLS
#5THERAPEUTIC MACROPHAGES
#6THREE DIMENSIONAL IMMUNOMECHANICAL ORGANOID MODEL
#7CHIMERIC ANTIGEN RECEPTORS FOR REMOVAL OF AMYLOID
#8P21 Expressing Monocytes for Cancer Cell Therapy
#9RE-EDITABLE TEMPLATES, CELLS, COMPOSITIONS AND METHODS OF MAKING
#10CELLS FOR THERAPY
#11DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#12GENERATION OF FUNCTIONAL NEUTROPHILS AND MACROPHAGES FROM INDUCED PLURIPOTENT STEM CELLS IN CHEMICALLY DEFINED CONDITIONS USING TRANSIENT EXPRESSION OF ETV2
#13ENHANCEMENT OF PHAGOCYTOSIS
#14CELL THERAPY FOR PATIENTS
#15COMPOSITIONS AND METHODS FOR SELECTIVE PHAGOCYTOSIS OF HUMAN CANCER CELLS
#16HOST CELLS BEARING KRAS BINDING PROTEIN AND KNOCKOUT OF ENDOGENOUS TCR AND METHODS OF USE THEREOF
#17EXTRACELLULAR VESICLES AND PARTICLES FROM IMMUNE CELLS FOR PROVIDING ANTICANCER ACTIVITY
#18NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#19Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
#20Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer
#21MAKING PROGRAMMED CELL-DERIVED VESICLES
#22SWITCH RECEPTORS AND MODIFIED IMMUNE CELLS
#23CELLS ENGINEERED WITH AN HLA-E AND HLA-G TRANSGENE
#24MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#25METHODS FOR TREATING CANCER WITH ENHANCED ANTIGEN PRESENTING CELLS
#26SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER
#27Myeloid Cells Overexpressing BCL2
#28PATHOLOGY-RESPONSIVE RECOMBINANT CELLS AND USES THEREOF
#29EX-VIVO PROLIFERATION OF HUMAN PHAGOCYTIC CELLS
#30NEURO-INTEGRATED BIOREACTOR SYSTEM FOR STUDYING JOINT PAIN AND TREATMENT THEREOF
#31STEM CELL-DERIVED EXTRACELLULAR VESICLES AND METHODS OF USE THEREOF
#32FORMULATIONS AND METHODS FOR CELLULAR THERAPIES INVOLVING CHIMERIC ANTIGEN RECEPTORS
#33MACROPHAGE-BASED THERAPY
#34CHIMERIC EFFEROCYTIC RECEPTORS IMPROVE APOPTOTIC CELL CLEARANCE AND ALLEVIATE INFLAMMATION
#35MACROPHAGE-SPECIFIC CHIMERIC ANTIGEN RECEPTOR, CONTROLLABLE POLARIZED MONOCYTE/MACROPHAGE EXPRESSING THE RECEPTOR, AND PREPARATION METHOD AND USE THEREOF
#36METHOD OF MODIFYING MACROPHAGE DIFFERENTIATION AND IMMUNITY
#37Discrete Microenvironment Chamber
#38MANNOSE-TARGETED COMPOSITIONS
#39COMPOSITIONS AND METHODS FOR ACTIVATING IMMUNE CELLS
#40TUMOR MICROENVIRONMENT-REGULATED CAR-MONOCYTE/MACROPHAGE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#41METHOD FOR DETERMINING THE ACTIVITY OF A DRUG OR DRUG CANDIDATE UNDER CONDITIONS OF MICROGRAVITY
#42TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS
#43METHOD OF CHEMICALLY TREATING OR CULTIVATING MACROPHAGES AND THEIR THERAPEUTIC APPLICATIONS IN FIBROTIC DISEASES
#44CULTURE MEDIUM AND METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN MACROPHAGES AND USE THEREOF
#45METHOD FOR PRODUCING PROLIFERATIVE MACROPHAGE-LIKE CELLS (pMAC)
#46CELL MICROPARTICLES CAPABLE OF TARGETING Folr2+ MACROPHAGES AND METHOD FOR PREPARING SAME
#47MODIFIED MONOCYTES/MACROPHAGES/DENDRITIC CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND USES IN DISEASES AND DISORDERS ASSOCIATED WITH PROTEIN AGGREGATES
#48GENETICALLY-MODIFIED IMMUNE CELLS COMPRISING A MICRORNA-ADAPTED SHRNA (SHRNAMIR)
#49COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM
#50COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CELL FUNCTION USING MODIFIED CELLS WITH GLYCOCALYX EDITING ENZYMES
#51CELLS AND METHODS
#52INNATE IMMUNE CHECKPOINT MODULATORS
#53INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF
#54SEQUENTIAL APPLICATION OF MACROPHAGES FOR WOUND HEALING
#55BIOTIN-AVIDIN CONTROLLED DELIVERY SYSTEMS
#56BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#57CELL CULTURE SYSTEM
#58CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#59SYSTEMS AND METHODS FOR MANUFACTURING OF THERAPEUTIC CELLS
#60Method of Targeting Cells and Associated Compositions
#61CELLULAR TARGETED ACTIVE INGREDIENT DELIVERY SYSTEM
#62Transgenic Macrophages, Chimeric Antigen Receptors, and Associated Methods
#63COMPOSITION FOR TREATING OR PREVENTING VASCULITIS AND DISEASES ASSOCIATED WITH VASCULITIS
#64METHOD FOR PRODUCING MACROPHAGES, DIFFERENTIATION INDUCING AGENT, DIFFERENTIATION INDUCTION KIT, METHOD FOR CULTURING MACROPHAGES, AGENT FOR PROMOTING MACROPHAGE PROPAGATION, KIT FOR PROMOTING MACROPHAGE PROLIFERATION, METHOD FOR MACROPHAGE PROLIFERATION, AND MACROPHAGES
#65ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF IN CELL THERAPY
#66PREPARATION OF ENGINEERED MYELOID CELLS
#67PLACENTAL MACROPHAGES FOR CELL THERAPY
#68POLYPEPTIDES, CELLS, AND METHODS INVOLVING ENGINEERED CD16
#69IL-4 EXPOSED MACROPHAGE EXOSOMES AND METHODS OF USE THEREOF
#70IMMUNE CELLS WITH REDUCED ANDROGEN RECEPTOR (AR) LEVEL, AND METHODS OF THEIR USE TO ENHANCE ANTI-CANCER THERAPY
#71CANCER MICROENVIRONMENT
#72Method for the Generation of Non-Transformed Macrophage Cell Line
#73COMPOSITIONS AND METHODS FOR ENHANCING STEM CELL SURVIVAL
#74COMPOSITIONS FOR AND METHODS OF TREATING A SUBJECT HAVING INFLAMMATION
#75IPSC-DERIVED IMMUNE CELLS IN PROPHYLAXIS AND TREATMENT OF AGE-ASSOCIATED AND NEURODEGENERATIVE DISEASES
#76METHOD FOR SEPARATING MIGRASOMES FROM MACROPHAGES
#77VECTOR SYSTEMS FOR DELIVERY OF TWO POLYNUCLEOTIDES AND METHODS OF MAKING AND USING SAME
#78MonoMac-1 Cells Expressing CD16 and CD163
#79CELL THERAPY
#80IMMUNE CELL WHICH HAS AN FC RECEPTOR ON ITS SURFACE AND TO WHICH IS GRAFTED A HYBRID MOLECULE COMPRISING AN ANTIBODY FC FRAGMENT AND AT LEAST ONE FIBRIN-DERIVED CITRULLINE PEPTIDE, AND USES THEREOF
#81METHOD FOR IMPROVING PROLIFERATIVE PROPERTIES OF COMMON MYELOID PROGENITOR CELLS (CMP) OR MYELOCYTIC PROGENITOR CELLS
#82SELF-POLARIZING IMMUNE CELLS
#83METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF
#84Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems
#85Use of Toll-Like Receptor 4 Agonists to Treat Inflammation and Tissue Injury
#86METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO PRO-INFLAMMATORY CELLS TO TREAT CANCER
#87HUMAN IPSC-DERIVED MACROPHAGES FOR LIVER REPAIR AND REGENERATION
#88Methods for the Treatment of Cancer, Inflammatory Diseases and Autoimmune Diseases
#89Treatment of Inflammatory Conditions or Diseases
#90CELL CONVERSION
#91CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY
#92Methods of Producing Improved Immune Cell Populations
#93Engineered Macrophages for Cancer Immunotherapy
#94CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#95Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer
#96COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS
#97METHOD FOR OBTAINING TUMOR-HYPOXIA EDUCATED REGENERATIVE MACROPHAGES AND USE THEREOF IN REGENERATIVE MEDICINE
#98METHODS AND COMPOSITIONS FOR MODULATING PERIPHERAL IMMUNE FUNCTION
#99SMALL EXTRACELLULAR VESICLES FOR ATTENUATING POST-OPERATIVE PAIN
#100GENETIC ENGINEERING OF MACROPHAGES FOR IMMUNOTHERAPY
#101METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR-MACROPHAGES AND USE OF SAME CELLS
#102CELLULAR TARGETED ACTIVE INGREDIENT DELIVERY SYSTEM
#103Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells
#104NEW REGULATORY MACROPHAGES AND USES THEREOF
#105Ultrathin Interfacial Layer on a Hydrogel to Direct its Surface Properties and Cell Adhesion
#106Macrophage Cell Therapy to Treat Orthopedic Injury
#107METHODS FOR EXPANDING A POPULATION OF ALVEOLAR MACROPHAGES IN A LONG TERM CULTURE
#108ENHANCEMENT OF ALLOGRAFT QUALITY BY POSTMORTEM DONOR REGENERATION
#109CRISPR RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS
#110GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS
#111DENDRITIC CELL ASSAY FOR INNATE IMMUNOGENICITY TO GENE THERAPY AGENTS
#112STAT-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF
#113USE OF AN IRAK4 MODULATOR FOR GENE THERAPY
#114HUMAN LYMPHOID TISSUE-ON-CHIP
#115SYSTEMS AND METHODS FOR PROMOTING REMYELINATION WITH FACTORS DERIVED FROM UMBILICAL CORD BLOOD MACROPHAGES
#116COMPOSITIONS FOR USE IN REDUCING INFLAMMATION
#117SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof
#118Nanohelix-substrate complex for controlling macrophage behavior, preparation method thereof, and method of controlling adhesion and polarization of macrophage by using the same
#119THERAPEUTIC REGENERATIVE CELLS
#120Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
#121METHOD OF TRANSFECTING MACROPHAGES
#122NATURAL KILLER CELL HAVING CONTROLLED ONCOLOGY-RELEATED GENE EXPRESSION, AND USE THEREOF
#123NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#124CHIMERIC NKG2D PROTEIN
#125MRNA TRANSFECTION OF IMMUNE CELLS
#126REGULATORY MACROPHAGES FOR TREATING ANGIOPATHIES
#127METHOD OF PRODUCING MACROPHAGES
#128CHIMERIC ANTIGEN RECEPTOR, MACROPHAGE EXPRESSING SAME, METHOD FOR ADJUSTING MACROPHAGE POLARIZATION, AND USE THEREOF
#129SIRPa Deficient Macrophages for Treating Cancer
#130METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS
#131MONOCYTE PURIFICATION METHOD IN PERIPHERAL BLOOD RAW MATERIAL COLLECTION/ FREEZING-THAWING STEP
#132METHOD FOR T CELL ACTIVATION FOR CANCER TREATMENT
#133PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING FIBRONECTIN TYPE III DOMAINS AND CELLS COMPRISING THE SAME
#134SYSTEM AND A METHOD FOR OBTAINING AN IMPROVED PLASMA EXTRACT
#135Application of TREM2hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction
#136MODIFIED MACROPHAGES, COMPOSITIONS AND USES THEREOF
#137UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS
#138MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#139MESODERMAL KILLER (MK) CELL
#140THERAPEUTIC CELL COMPOSITIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#141TEIPP PEPTIDE VARIANT AND USES THEREOF
#142GENERATION OF MATURE KUPFFER CELLS
#143COMPOSITIONS AND USES THEREOF
#144Monocyte and macrophage binding aptamers and their application
#145METHOD OF GENERATION OF LYMPHO-MYELOID NICHES
#146MODULATION OF STIMULATORY AND NON-STIMULATORY MYELOID CELLS
#147COMPOSITION AND METHOD FOR INDUCING DIFFERENTIATION INTO MYELOID CELLS, AND USE THEREOF
#148HDAC6-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF
#149METHOD FOR PREPARING MONOCYTES DERIVED SIGNALING CELLS MIXTURE AND USES THEREOF
#150ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
#151Macrophage CAR (MOTO-CAR) In Immunotherapy
#152Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#153METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
#154LPS Priming of Stromal Cells to Generate LPS-Specific Exosome Educated Macrophages
#155METHOD FOR PREPARING CELL MEMBRANE-COATED NANO TOPOLOGICALARRAY AND USE THEREOF
#156Composition for hair regeneration comprising macrophage-derived extracellular vesicle mimetics
#157METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO PRO-INFLAMMATORY CELLS TO TREAT CANCER
#158Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#159CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#160METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES
#161ANTI-ROBO1 CAR-T CELL, AND PREPARATION AND APPLICATION THEREOF
#162METHODS FOR GROWING AFRICAN SWINE FEVER VIRUS IN FETAL PORCINE LUNG ALVEOLAR MACROPHAGE CELLS
#163P21 Expressing Monocytes for Cancer Cell Therapy
#164BOVINE MONOCYTE-DERIVED MACROPHAGE IN CULTURE SYSTEM AND METHODS FOR MEASURING INNATE IMMUNITY
#165Human lymphoid tissue-on-chip
#166Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient
#167Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer
#168DEVICES, SYSTEMS, AND KITS FOR ELECTRO-MECHANICAL DELIVERY AND METHODS OF USE THEREOF
#169Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer
#170METHODS AND CLINICAL PROTOCOLS AND KITS PERTAINING TO MAKING AND USING THERAPEUTIC COMPOSITIONS FOR CELLULAR TREATMENT
#171CELL-CONTAINING PHARMACEUTICAL COMPOSITION
#172CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#173COMPOSITION FOR INDUCING DIRECT CONVERSION OF SOMATIC CELL INTO COMMON MYELOID PROGENITOR AND USE THEREOF
#174Treatment and diagnosis of inflammatory disorders
#175CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#176CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#177COMPOSITION FOR TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#178METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME
#179Method of generating hemangioblasts
#180METHOD FOR T CELL ACTIVATION FOR CANCER TREATMENT
#181IMMUNOMODULATION BY AMNIOTIC FLUID MESENCHYMAL STEM CELLS
#182CELL COMPOSITION, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE COMPRISING SAME
#183Use of Toll-Like Receptor 4 Agonists to Treat Inflammation and Tissue Injury
#184CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#185Nanohelix-substrate complex for controlling macrophage behavior, preparation method thereof, and method of controlling adhesion and polarization of macrophage by using the same
#186MUTATED INTERLEUKIN-34 (IL-34) POLYPEPTIDES AND USES THEREOF IN THERAPY
#187Methods for Modulating Macrophage Activity
#188INDUCTION METHOD FOR MACROPHAGE, ANTI-INFLAMMATORY MACROPHAGE-INDUCING AGENT, AND PHARMACEUTICAL COMPOSITION
#189Crosslinking agent, preparation process and uses thereof, hydrogel and biodegradable cryogel comprising crosslinking agent
#190Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#191Target-primed macrophages and therapeutic uses thereof
#192DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#193Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#194Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
#195Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#196Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
#197Methods and reagents for modulating macrophage phenotype
#198METHODS OF IDENTIFYING THERAPEUTIC TARGETS FOR TREATING ANGIOGENESIS
#199Constructs for chimeric antigen receptors
#200Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#201Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#202Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#203Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor
#204NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS
#205Method for fabrication of three-dimensional lung organoid comprising human stem cell-derived alveolar macrophage
#206Interaction of fibroblasts and immune cells for activation and uses thereof
#207METHOD OF MODIFYING MACROPHAGE DIFFERENTIATION AND IMMUNITY
#208INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION
#209Method of controlling adhesion and polarization of macrophages by using nanobarcode
#210Therapeutic cell compositions and methods of manufacturing and use thereof
#211CD11B + PIEZO-1 + MACROPHAGES AND USES THEREOF
#212Polypeptides, cells, and methods involving engineered CD16
#213Method of making exosomes from tumor cell/antigen presenting cell hybrid cells
#214Cellular Targeted Label Delivery System
#215Mammalian alveolar macrophages derived from pluripotent cells
#216Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof
#217Engineered Cells for Inducing Tolerance
#218BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#219COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEMYELINATING CONDITIONS
#220Nano-ligand for promoting cell adhesion and regeneration of macrophages and method of promoting cell adhesion and regeneration of macrophages by using the same
#221METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS
#222GENOME ENGINEERING PRIMARY MONOCYTES
#223CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#224METHODS OF MEDIATING MACROPHAGE PHENOTYPES
#225Development of dual whole cell-based vaccine against pancreatic cancer
#226Compositions and Methods for Selective Phagocytosis of Human Cancer Cells
#227MESENCHYMAL STROMAL CELL EXOSOME-TREATED MONOCYTES AND USES THEREOF
#228Transgenic macrophages, chimeric antigen receptors, and associated methods
#229METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOPETROSIS
#230COMPOSITIONS AND METHODS FOR MODULATING MONOCYTE AND MACROPHAGE INFLAMMATORY PHENOTYPES AND IMMUNOTHERAPY USES THEREOF
#231METHODS AND MATERIALS FOR TREATING CANCER
#232Cell Reprogramming Therapy
#233STEM-CELL DERIVED MYELOID CELLS, GENERATION AND USE THEREOF
#234Supernatant from a coculture of macrophages and irradiated leukocytes, for controlling tumour progression or restoring anti-tumor immunity
#235Engineered Exosomes to Detect and Deplete Pro-Tumorigenic Macrophages
#236Ultrathin interfacial layer on a hydrogel to direct its surface properties and cell adhesion
#237Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#238AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
#239ANTI-LILRB ANTIBODIES AND USES THEREOF
#240BIOMOLECULAR COMPOSITES COMPRISING MODIFIED CELL GHOSTS
#241CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#242Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells
#243Optical-quality surface that imparts spatial control of macrophage fusion
#244Immortalization of Splenic and Peripheral Blood Macrophages Using a Multi-Cistronic V-RAF/V-MYC Lentivirus
#245ENGINEERED IMMUNE CELLS AS DIAGNOSTIC PROBES OF DISEASE
#246Method of selectively differentiating undifferentiated macrophage into M1 macrophage
#247In vitro immune synapse system and method of in vitro evaluating immune response using the same
#248Cell culture system
#249Macrophage-based therapy
#250Differentiation of pluripotent cells into microglial cells expressing IBA-1
#251GENERATION OF FUNCTIONAL NEUTROPHILS AND MACROPHAGES FROM INDUCED PLURIPOTENT STEM CELLS IN CHEMICALLY DEFINED CONDITIONS USING TRANSIENT EXPRESSION OF ETV2
#252MODEL SYSTEM OF LIVER FIBROSIS AND METHOD OF MAKING AND USING THE SAME
#253Genome Edited iPSC-Derived Monocytes Expressing Trophic Factors
#254METHOD FOR ACTIVATING HELPER T CELL
#255Bioengineered in vitro 3D model of human atherosclerotic plaque
#256Methods for obtaining regulatory t cells and uses thereof
#257NEW IMMUNOREGULATORY CELLS AND METHODS FOR THEIR PRODUCTION
#258Oncolytic herpes simplex virus infected cells
#259Chimeric endocytic receptors and method of use thereof
#260COMPOSITION AND KIT FOR DIFFERENTIATING CANCER ASSOCIATED FIBROBLASTS INTO MACROPHAGES, AND METHOD OF USING THE SAME
#261Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#262IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#263Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof
#264Method of Treating Respiratory Tract Infection
#265Genetic engineering of macrophages for immunotherapy
#266Cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor
#267Differentiation Of Immunocytes Using Pluripotent Stem Cells
#268Composition having tissue-repairing activity, and use therefor
#269Methods and compositions for modulating peripheral immune function
#270GENERATION OF HEMATOPOIETIC PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS
#271GENE THERAPY
#272IL-31 improves efficacy of macrophage-based adoptive cell therapy for cancer
#273FILTER CONTAINER FOR SEPARATING CELLS AND FILTER DEVICE FOR SEPARATING CELLS
#274ANTI-INFLAMMATORY EXOSOMES FROM INFLAMED CELLS OR TISSUES
#275Swine Comprising Modified CD163 and Associated Methods
#276Passive antibody dependent cell-mediated activation
#277Cellular Targeted Label Delivery System
#278Cellular targeted active ingredient delivery system
#279MonoMac-1 cells expressing CD16 and CD163
#280Modulation of stimulatory and non-stimulatory myeloid cells
#281Polypeptides, cells, and methods involving engineered CD16
#282Transgenic macrophages, chimeric antigen receptors, and associated methods
#283Method of generating multi-lineage potential cells and multi-lineage potential cells produced therefrom
#284Chimeric antigen receptors and uses thereof
#285NEW USE
#286METHODS OF GENERATING HEPATIC MACROPHAGES AND USES THEREOF
#287CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#288Humanized mouse model
#289METHOD FOR INDUCING TRANSDIFFERENTIATION OF IMMUNE CELLS BASED ON EXOSOMES
#290METHODS OF ADOPTIVE CELL THERAPY
#291CELL THERAPY FOR PATIENTS
#292Methods and reagents for modulating macrophage phenotype
#293Co-culture system and method for in vitro assessment of reverse cholesterol transport
#294Enhanced Gene Delivery to Natural Killer Cells, Hematopoietic Stem Cells and Macrophages
#295Integrated sensor and service port for HVAC equipment or HVAC system
#296LPS priming of stromal cells to generate LPS-specific exosome educated macrophages
#297METHOD FOR MANUFACTURING NATURAL KILLER T (NKT) CELL - STIMULATING DENDRITIC CELL, METHOD FOR MANUFACTURING CELL COMPOSITION CONTAINING THE NKT CELL STIMULATING DENDRITIC CELL AND NKT CELL, AND CELL COMPOSITION CONTAINING THEREOF
#298Human lymphoid tissue-on-chip
#299APPARATUS AND METHOD FOR BATCH PHOTOACTIVATION OF MONONUCLEAR CELLS WITH CRYOPRESERVATION
#300Cell preparation and method for producing cell preparation